Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Recruiting now

Conditions studied: Prostate Cancer

In brief

This is a retrospective monoinstitutional study which analyses the results of advanced radiotherapy (IGRT, IMRT, SBRT, and PET-guided) performed for radical, adjuvant, or salvage purposes in patients with low, intermediate, high, and very high-risk prostate cancer, or with biochemical, lymph node, or oligometastatic recurrence treated between 2004 and 2024. Approved by Ethics Committee of IRCCS San Raffaele Hospital Approval Number: 187/INT/2021, 03/02/2022 Amendment approved by Ethics Committee 1, Lombardy Region Approval number CET Em. 194-2024, 22/05/2024

Key facts

Study ID

NCT06546267

Run by

IRCCS San Raffaele

People needed

2500

Starts

2022-02-14

Expected to finish

2027-12-14

Last updated by the study team

2025-06-11

Who can join

Age: 18 and older, up to 95. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Prostate cancer patients, > 18 years old, treated with IGRT, IMRT, SBRT

You may not qualify if…

• other tumors
• > 95 years old

Where it is running

• IRCCS San Raffaele Scientific Institute — Milan, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.